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‘Improving Palliative Care for Cancer’ is an independent review
that gives a fascinating overview of palliative care in the United
States. Prepared in accordance with procedures approved by the
National Research Council’s Report Review Committee it has been
reviewed by a panel of American experts and offers an opportunity
to learn of the services, problems and aspirations of a rapidly
expanding area of cancer medicine. This book is a report that
‘deﬁnes the major barriers that keep people from receiving excel-
lent palliative care, as needed, throughout the course of their
illness with cancer and recommends a series of steps forward.’
Throughout this report (it is a ‘report’ that is 300 pages in length)
one can not help but make comparisons between palliative care in
the US and in the UK. The problems presented to Palliative Care
Services by the economic environment imposed by the American
health care system are very different to problems faced by palliative
care services in the UK. There are lessons to be learnt from a reim-
bursement system that appears to disadvantage patients who have
palliative care needs. For example, there are obvious shortcomings
presented by a reimbursement system that will only support
patients in a palliative care programme for 6 months, which
focuses palliative care on end of life issues. This limited approach
to care will be alien to specialists in the UK where many palliative
care services work in partnership with oncology services, support-
ing patients through treatment as well as in the terminal phase of
illness.
The report is divided into two parts. The ﬁrst part is an execu-
tive summary with background information, barriers to excellent
palliative care and end of life care, conclusions and recommenda-
tions. One key recommendation is to designate cancer centres as
centres of excellence in symptom control and palliative care which
can become model services with high quality research and educa-
tion. This theme has a familiar sound to those of us in the UK
where cancer centres are now established. However, the mechan-
isms by which this high quality, evidence based care are to be
disseminated are not detailed. In the UK we have attempted to
address inequity in cancer, palliative care and supportive care by
establishing Clinically Managed Networks. I felt there needed to
be an attempt to discuss this important issue in more detail in this
report. Other recommendations include developing multi profes-
sional guidelines, developing information services and ensuring
that there is adequate palliative care representation on the National
Cancer Institutes’ advisory bodies. In addition it is recommended
that private insurers should provide adequate compensation for
end-of-life care.
The second part comprises eight commissioned papers on key
areas in palliative care in the United States. There is a common
format to these. The current ‘state of play’ is presented with
well-referenced discussions that are understandably focused on
American literature. The problems are then presented and then
there is debate about future directions. Finally, conclusions and
recommendations are drawn. The contents of these papers are
mixed and in places open to criticism. There is a noticeable lack
of information on bereavement services, a review of symptom
control that lacked depth, and a polarised view of palliative care
research. However, for the informed reader, this report would form
the basis for discussion and debate about many key issues in
contemporary palliative care for patients with cancer. I personally
found some of the recommendations repetitive and lacking focus
or clear direction. My concern was that they could potentially be
‘wish lists’ that had little prospect of being implemented. In addi-
tion, I can’t help but feel that there will need to be a huge specialist
and bureaucratic resource to carry out all these ambitious recom-
mendations. However, if they are to be supported and funded then
this could certainly place palliative care in the USA in a world-
leading position. One can only wish Palliative Care in America
good luck in its task.
Improving Palliative Care for Cancer is a major review of pallia-
tive care in the US in its totality. There has never been a similar
review in the UK. Our services have evolved in response to the
changing needs of cancer care. Perhaps the continuing success of
the speciality in the UK is a reﬂection of this approach. Evolution
or revolution? Read the report to decide – there is much food for
thought.
Adrian Tookman
Royal Free Hospital
London, UK
British Journal of Cancer (2002) 87, 1481
ã 2002 Cancer Research UK All rights reserved 0007–0920/02 $25.00
www.bjcancer.com